Global Active Pharmaceutical Ingredients Market Insights, Size and Growth Forecast To 2027
The global pharmaceutical contract development market is expected to grow at a CAGR of ~6.9% from 2020 to reach ~181.0 billion by 2027. The growth is primarily attributed to growing demand for generics and specialty medicines, increasing awareness for biological therapies, rapidly growing investments in R&D & manufacturing technologies by CDMOs, growing nuclear medicine sector and advancing cell & gene therapies. However, lack of skilled professionals and IPR issues are expected to hinder the growth of the market. Increasing need for novel drugs and growth in biologics offer significant growth opportunities for the market players. “The Final Report will cover the impact analysis of COVID-19 on this industry (Global and Regional Market).” Access Full Report? Inquire Here@ https://www.sperresearch.com/report-store/Pharmaceutical-Contract-Development.aspx?sample=1 By Service: The biologics manufacturing services segment to grow at highest CAGR Based on ...